terms |
afelimomab |
As nouns the difference between terms and afelimomab
is that
terms is while
afelimomab is a monoclonal antibody that reduces the concentration of interleukin-6 in patients with sepsis.
sepsis |
afelimomab |
As nouns the difference between sepsis and afelimomab
is that
sepsis is (pathology) a serious medical condition in which the whole body is inflamed, and a known or suspected infection is present while
afelimomab is a monoclonal antibody that reduces the concentration of interleukin-6 in patients with sepsis.
interleukin |
afelimomab |
As nouns the difference between interleukin and afelimomab
is that
interleukin is (biochemistry) any of a group of cytokine proteins important in the regulation of lymphocyte function while
afelimomab is a monoclonal antibody that reduces the concentration of interleukin-6 in patients with sepsis.
concentration |
afelimomab |
As nouns the difference between concentration and afelimomab
is that
concentration is the act, process or ability of concentrating; the process of becoming concentrated, or the state of being concentrated while
afelimomab is a monoclonal antibody that reduces the concentration of interleukin-6 in patients with sepsis.